Suppr超能文献

腺嘌呤核苷和血小板。

Adenosine and blood platelets.

机构信息

Departments of Medicine and Biochemistry, Whitaker Cardiovascular Institute, and Evans Center for Interdisciplinary Biomedical Research, Boston University School of Medicine, CVI, 700 Albany St., Boston, MA, 02118, USA.

出版信息

Purinergic Signal. 2011 Sep;7(3):357-65. doi: 10.1007/s11302-011-9220-4. Epub 2011 Feb 8.

Abstract

Adenosine is an important regulatory metabolite and an inhibitor of platelet activation. Adenosine released from different cells or generated through the activity of cell-surface ectoenzymes exerts its effects through the binding of four different G-protein-coupled adenosine receptors. In platelets, binding of A(2) subtypes (A(2A) or A(2B)) leads to consequent elevation of intracellular cyclic adenosine monophosphate, an inhibitor of platelet activation. The significance of this ligand and its receptors for platelet activation is addressed in this review, including how adenosine metabolism and its A(2) subtype receptors impact the expression and activity of adenosine diphosphate receptors. The expression of A(2) adenosine receptors is induced by conditions such as oxidative stress, a hallmark of aging. The effect of adenosine receptors on platelet activation during aging is also discussed, as well as potential therapeutic applications.

摘要

腺苷是一种重要的调节代谢物和血小板激活抑制剂。不同细胞释放的腺苷或通过细胞表面ectoenzymes 的活性产生的腺苷,通过结合四种不同的 G 蛋白偶联腺苷受体发挥其作用。在血小板中,A(2)亚型(A(2A)或 A(2B))的结合导致细胞内环磷酸腺苷的浓度升高,从而抑制血小板的激活。本综述讨论了这种配体及其受体对血小板激活的意义,包括腺苷代谢及其 A(2)亚型受体如何影响二磷酸腺苷受体的表达和活性。A(2)腺苷受体的表达是由氧化应激等衰老特征的条件诱导的。本文还讨论了在衰老过程中腺苷受体对血小板激活的影响,以及潜在的治疗应用。

相似文献

1
Adenosine and blood platelets.
Purinergic Signal. 2011 Sep;7(3):357-65. doi: 10.1007/s11302-011-9220-4. Epub 2011 Feb 8.
2
Physiological implications of adenosine receptor-mediated platelet aggregation.
J Cell Physiol. 2011 Jan;226(1):46-51. doi: 10.1002/jcp.22379.
3
Gene expression profiling for the identification of G-protein coupled receptors in human platelets.
Thromb Res. 2008;122(1):47-57. doi: 10.1016/j.thromres.2007.08.014. Epub 2007 Oct 24.
5
Off-target effect of the Epac agonist 8-pCPT-2'-O-Me-cAMP on P2Y12 receptors in blood platelets.
Biochem Biophys Res Commun. 2013 Aug 9;437(4):603-8. doi: 10.1016/j.bbrc.2013.07.007. Epub 2013 Jul 12.

引用本文的文献

5
Endothelial Cell Dysfunction and Increased Cardiovascular Risk in Patients With Chronic Kidney Disease.
Circ Res. 2023 Apr 14;132(8):970-992. doi: 10.1161/CIRCRESAHA.123.321752. Epub 2023 Apr 13.
6
Effects of uridine and nucleotides on hemostasis parameters.
J Thromb Thrombolysis. 2023 May;55(4):626-633. doi: 10.1007/s11239-023-02793-y. Epub 2023 Mar 24.
9
Assessment of myocardial salvage in patients with STEMI undergoing thrombolysis: ticagrelor versus clopidogrel.
BMC Cardiovasc Disord. 2022 Jul 2;22(1):301. doi: 10.1186/s12872-022-02735-1.
10
Platelet-Mediated Transfer of Cardioprotection by Remote Ischemic Conditioning and Its Abrogation by Aspirin But Not by Ticagrelor.
Cardiovasc Drugs Ther. 2023 Oct;37(5):865-876. doi: 10.1007/s10557-022-07345-9. Epub 2022 May 21.

本文引用的文献

1
Sensing and responding to hypoxia, molecular and physiological mechanisms.
Integr Comp Biol. 2002 Jul;42(3):463-8. doi: 10.1093/icb/42.3.463.
2
Signaling during platelet adhesion and activation.
Arterioscler Thromb Vasc Biol. 2010 Dec;30(12):2341-9. doi: 10.1161/ATVBAHA.110.207522. Epub 2010 Nov 11.
3
The aging stress response.
Mol Cell. 2010 Oct 22;40(2):333-44. doi: 10.1016/j.molcel.2010.10.002.
4
Oxidative stress and aging.
J Nephrol. 2010 Sep-Oct;23 Suppl 15:S29-36.
5
Dynamic regulation of fibrinogen: integrin αIIbβ3 binding.
Biochemistry. 2010 Nov 2;49(43):9217-25. doi: 10.1021/bi1009858.
6
The role of oxidative stress in the aging process.
ScientificWorldJournal. 2010 Jun 15;10:1121-8. doi: 10.1100/tsw.2010.94.
7
Oxidative stress and vascular function: implications for pharmacologic treatments.
Curr Hypertens Rep. 2010 Jun;12(3):154-61. doi: 10.1007/s11906-010-0103-9.
8
Oxidative stress and central cardiovascular regulation. - Pathogenesis of hypertension and therapeutic aspects -.
Circ J. 2010 May;74(5):827-35. doi: 10.1253/circj.cj-10-0153. Epub 2010 Apr 15.
9
The thromboxane/endoperoxide receptor (TP): the common villain.
J Cardiovasc Pharmacol. 2010 Apr;55(4):317-32. doi: 10.1097/fjc.0b013e3181d8bc8a.
10
Thrombin receptor antagonism -the potential of antiplatelet medication SCH 530348.
Expert Opin Pharmacother. 2010 Apr;11(6):1015-22. doi: 10.1517/14656561003720471.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验